Eric A Hughes
CIK 1938678 · View on SEC EDGAR ↗
Insider
First SEC filing: June 12, 2026 · Latest: June 12, 2026
On this page
Insider at
Insider transactions
0 buys (P)
5 sells (S)
Net:
$-4,173,581
+ 31 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
31 other filings hidden
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Aug. 3, 2026 | TEVA | S 10b5-1 | 25,578 | $34.88 | $892,161 | 134,877 Direct | -15.94% | Disposed | 6.1% (price as of 2026-08-20) |
| March 5, 2026 | TEVA | S 10b5-1 | 9,533 | $31.67 | $301,910 | 107,711 Direct | -8.13% | Disposed | 16.8% (price as of 2026-08-20) |
| March 4, 2026 | TEVA | S 10b5-1 | 11,277 | $32.46 | $366,051 | 97,590 Direct | -10.36% | Disposed | 14.0% (price as of 2026-08-20) |
| March 3, 2026 | TEVA | S 10b5-1 | 68,685 | $32.36 | $2,222,647 | 85,616 Direct | -44.51% | Disposed | 14.3% (price as of 2026-08-20) |
| March 3, 2026 | TEVA | S 10b5-1 | 12,077 | $32.36 | $390,812 | 12,823 Direct | -48.50% | Disposed | 14.3% (price as of 2026-08-20) |
| Aug. 1, 2025 | TEVA | S 10b5-1 | 52,742 | $15.16 | $799,569 | 0 Direct | -100.00% | Disposed | 144.1% (price as of 2026-08-20) |
| March 5, 2025 | TEVA | S 10b5-1 | 8,077 | $15.91 | $128,505 | 0 Direct | -100.00% | Disposed | 132.6% (price as of 2026-08-20) |
| March 4, 2025 | TEVA | S 10b5-1 | 15,174 | $15.73 | $238,687 | 8,077 Direct | -65.26% | Disposed | 135.2% (price as of 2026-08-20) |
| March 4, 2025 | TEVA | S 10b5-1 | 5,174 | $15.56 | $80,507 | 0 Direct | -100.00% | Disposed | 137.8% (price as of 2026-08-20) |
| March 3, 2025 | TEVA | S 10b5-1 | 19,726 | $16.19 | $319,364 | 5,174 Direct | -79.22% | Disposed | 128.5% (price as of 2026-08-20) |
| Aug. 9, 2024 | TEVA | S | 45,060 | $17.38 | $783,143 | 0 Direct | -100.00% | Disposed | 112.9% (price as of 2026-08-20) |
| Aug. 1, 2024 | TEVA | S 10b5-1 | 24,537 | $17.25 | $423,263 | 45,060 Direct | -35.26% | Disposed | 114.5% (price as of 2026-08-20) |
| March 4, 2024 | TEVA | S 10b5-1 | 8,045 | $13.34 | $107,320 | 16,855 Direct | -32.31% | Disposed | 177.4% (price as of 2026-08-20) |
| Aug. 1, 2023 | TEVA | S 10b5-1 | 52,742 | $8.30 | $437,759 | 0 Direct | -100.00% | Disposed | 345.8% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Aug. 3, 2026 | TEVA | Restricted Share Units | Ordinary Shares [F1] (52,744) | — | — | 52,744 | Disposed |
| June 11, 2026 | GLUE | Stock Option (Right to Buy) | Common Stock (25,800) | $17.10 | June 11, 2036 | 25,800 | Acquired |
| March 5, 2026 | TEVA | Restricted Share Units | Ordinary Shares [F1] (19,654) | — | — | 19,654 | Disposed |
| March 4, 2026 | TEVA | Restricted Share Units | Ordinary Shares [F1] (50,643) | — | — | 50,643 | Acquired |
| March 4, 2026 | TEVA | Restricted Share Units | Ordinary Shares [F1] (23,251) | — | — | 23,251 | Disposed |
| March 3, 2026 | TEVA | Restricted Share Units | Ordinary Shares [F1] (141,478) | — | — | 141,478 | Disposed |
| March 3, 2026 | TEVA | Restricted Share Units | Ordinary Shares [F1] (24,900) | — | — | 24,900 | Disposed |
| Jan. 27, 2026 | TEVA | Restricted Share Units | Ordinary Shares [F3] (141,478) | — | — | 141,478 | Acquired |
| Aug. 1, 2025 | TEVA | Restricted Share Units | Ordinary Shares [F1] (52,742) | — | — | 52,742 | Disposed |
| June 13, 2025 | GLUE | Stock Option (Right to Buy) | Common Stock (30,700) | $4.91 | June 13, 2035 | 30,700 | Acquired |
| March 5, 2025 | TEVA | Restricted Share Units | Ordinary Shares [F3] (78,616) | — | — | 78,616 | Acquired |
| March 4, 2025 | TEVA | Restricted Share Units | Ordinary Shares [F1] (0) | — | — | 23,251 | Disposed |
| March 3, 2025 | TEVA | Restricted Share Units | Ordinary Shares [F1] (24,900) | — | — | 24,900 | Disposed |
| Dec. 11, 2024 | GLUE | Stock Option (Right to Buy) | Common Stock (44,200) | $8.51 | Dec. 10, 2034 | 44,200 | Acquired |
| Aug. 1, 2024 | TEVA | Restricted Share Units | Ordinary Shares [F1] (52,742) | — | — | 52,742 | Disposed |
| March 4, 2024 | TEVA | Restricted Share Units | Ordinary Shares [F1] (93,005) | — | — | 93,005 | Acquired |
| March 3, 2024 | TEVA | Restricted Share Units | Ordinary Shares [F1] (24,900) | — | — | 24,900 | Disposed |
| Aug. 1, 2023 | TEVA | Restricted Share Units | Ordinary Shares [F1] (52,742) | — | — | 52,742 | Disposed |
| March 3, 2023 | TEVA | Restricted Share Units | Ordinary Shares [F3] (99,601) | — | — | 99,601 | Acquired |
| Aug. 1, 2022 | TEVA | Restricted Share Units | Ordinary Shares [F3] (210,970) | — | — | 210,970 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
TEVA
Global R&D and Chief Medical Officer| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $829,231 | — | — | — | $1,569,817 | — | $149,902 | $6,298,933 |
| 2024 | $753,846 | — | — | — | $1,116,748 | — | $134,218 | $5,754,787 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.